A multi-institutional evaluation of the safety and efficacy of bevacizumab for recurrent, platinum-resistant ovarian cancer.

Published

Conference Paper

Full Text

Duke Authors

Cited Authors

  • WriQht, JD; Alvarezsecord, A; Numnum, TM; Rocconi, RP; Powell, MA; Berchuck, A; Alvarez, RD; Trinkaus, K; Rader, JS; Mutch, DG

Published Date

  • June 20, 2006

Published In

Volume / Issue

  • 24 / 18

Start / End Page

  • 260S - 260S

Published By

Pages

  • 1

International Standard Serial Number (ISSN)

  • 0732-183X

Conference Name

  • 42nd Annual Meeting of the American-Society-of-Clinical-Oncology

Conference Location

  • Atlanta, GA

Conference Start Date

  • June 2, 2006

Conference End Date

  • June 6, 2006